Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the combination of necitumumab, trastuzumab, and osimertinib for refractory EGFR-mutated stage IV…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors [EARLY_Phase 1]
This early-phase (Phase 1) trial assesses the safety, dosimetry, and preliminary efficacy signals of the radiopharmaceutical 177Lu-INN805 in…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma [Phase 4]
Phase 4 clinical trial comparing pemetrexed-free versus pemetrexed-based immunochemotherapy in metastatic TTF-1 negative lung adenocarcinoma…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non-Oligometastatic Stage IV Non-Small Cell Lung Cancer [NA]
A multicenter Phase III randomized trial from Guizhou Medical University evaluating three-dimensional radiotherapy for primary tumors in non…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients [NA]
Clinical trial update on HGXJT for bone-metastatic non-small cell lung cancer, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases? [NA]
This clinical trial update discusses the role of CyberKnife radiosurgery for patients with multiple brain metastases, including individuals …
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial from AstraZeneca evaluating a KRAS G12D-targeted TCR-T cell therapy in adults with unresectable, advanced, or metas…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Therapy for Advanced NSCLC With EGFR 19delins Mutation [EARLY_Phase 1]
An early-phase (Phase 1) study of an investigational therapy for advanced non-small cell lung cancer with EGFR 19delins mutation. The trial …
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update discusses the Phase 1/Phase 2 study of AK112 and AK104, with or without chemotherapy, in advanced non-small cell …
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study of YL202 in Patients With Advanced Solid Tumors [Phase 2]
A Phase 2 trial of YL202 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, colorectal ca…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating RAS(ON) inhibitors in patients with advanced non-small cell lung cancer harboring KRAS, NRAS, or HR…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) [Phase 2, Phase 3]
A Phase 2/3 clinical trial sponsored by Hoffmann-La Roche is evaluating the efficacy and safety of multiple targeted therapies for non-small…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC [Phase 2]
Phase 2 trial to evaluate adjuvant tislelizumab in high-risk stage I non-small cell lung cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive) [Phase 2]
A Phase 2 clinical trial investigates whether using ctDNA-minimal residual disease status to guide escalation of Ivonescimab plus Docetaxel …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating a triple combination of tocilizumab, ipilimumab, and nivolumab for advanced melanoma, non-small cel…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors [Phase 1]
Phase I trial update of Tolododekin Alfa (ANK-101) in advanced solid tumors. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 2]
Phase 2 study evaluating JYP0015 in advanced solid tumors with RAS mutations is currently recruiting, including pancreatic ductal adenocarci…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating difluoromethylornithine (DFMO) as an immunotherapeutic target in STK11-deficient non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations [Phase 2]
Phase 2 trial evaluating the efficacy and safety of osimertinib given before chemoradiation and as maintenance therapy in patients with Stag…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Stereotactic Radiotherapy (SBRT) of Lung Metastasis [Phase 2]
A Phase 2 clinical trial is evaluating stereotactic body radiotherapy (SBRT) for treating lung metastases in patients with non-small cell lu…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care [NA]
This clinical trial update notes an ongoing randomized study comparing molecular tumor board–assisted care to usual care for non-small cell …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the efficacy and safety of multiple therapies in cohorts of participants wit…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC [Phase 2]
A Phase 2 study evaluating BL-M07D1 in combination with pembrolizumab for unresectable locally advanced or metastatic HER2-overexpressing no…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update evaluating Minnelide in combination with Osimertinib for advanced EGFR-mutated non-small cell lung cancer; the…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE) [Phase 2]
A phase 2 exploratory trial studying the combination of atezolizumab and bevacizumab in hepatocellular carcinoma and metastatic non-small ce…